AU572364B2 - 4((alpha-methyl)-2,3-dimethylbenzyl)imidazole as a sedative-analgesic agent in the veterinary field - Google Patents

4((alpha-methyl)-2,3-dimethylbenzyl)imidazole as a sedative-analgesic agent in the veterinary field

Info

Publication number
AU572364B2
AU572364B2 AU49971/85A AU4997185A AU572364B2 AU 572364 B2 AU572364 B2 AU 572364B2 AU 49971/85 A AU49971/85 A AU 49971/85A AU 4997185 A AU4997185 A AU 4997185A AU 572364 B2 AU572364 B2 AU 572364B2
Authority
AU
Australia
Prior art keywords
imidazole
methyl
sedative
dimethylbenzyl
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU49971/85A
Other languages
English (en)
Other versions
AU4997185A (en
Inventor
Arto Johannes Karjalainen
Kauko Oiva Antero Kurkela
Antti Tapani Vaha-Vahe
Outi Marilta Vainio-Kivinen
Raimo Einari Virtanen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Farmos Yhtyma Oy
Original Assignee
Farmos Yhtyma Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmos Yhtyma Oy filed Critical Farmos Yhtyma Oy
Publication of AU4997185A publication Critical patent/AU4997185A/en
Application granted granted Critical
Publication of AU572364B2 publication Critical patent/AU572364B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Stringed Musical Instruments (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU49971/85A 1984-12-04 1985-11-15 4((alpha-methyl)-2,3-dimethylbenzyl)imidazole as a sedative-analgesic agent in the veterinary field Expired AU572364B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI844786A FI844786A0 (fi) 1984-12-04 1984-12-04 Terapeutiskt utnyttjbar foerening.
FI844786 1984-12-04

Publications (2)

Publication Number Publication Date
AU4997185A AU4997185A (en) 1986-06-12
AU572364B2 true AU572364B2 (en) 1988-05-05

Family

ID=8520010

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49971/85A Expired AU572364B2 (en) 1984-12-04 1985-11-15 4((alpha-methyl)-2,3-dimethylbenzyl)imidazole as a sedative-analgesic agent in the veterinary field

Country Status (11)

Country Link
US (1) US4670455A (OSRAM)
EP (1) EP0187471B1 (OSRAM)
JP (1) JPS61134314A (OSRAM)
AT (1) ATE65694T1 (OSRAM)
AU (1) AU572364B2 (OSRAM)
DE (1) DE3583670D1 (OSRAM)
DK (1) DK163960C (OSRAM)
FI (1) FI844786A0 (OSRAM)
IE (1) IE58269B1 (OSRAM)
NZ (1) NZ213604A (OSRAM)
ZA (1) ZA858416B (OSRAM)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI864570A0 (fi) * 1986-11-11 1986-11-11 Farmos Oy Terapeutiskt anvaendbar foerening.
GB2206880B (en) 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative
GB2215206B (en) * 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care
US5344840A (en) * 1988-02-29 1994-09-06 Orion-Yhtyma Oy 4-substituted imidazole derivatives useful in perioperative care
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
AR015744A1 (es) * 1998-04-01 2001-05-16 Orion Corp Uso de dexmedetomidina para sedacion en terapia intensiva
FI20041425A0 (fi) * 2004-11-05 2004-11-05 Orion Corp Transmukosaalinen veterinäärinen koostumus
US7795263B2 (en) * 2008-07-08 2010-09-14 Wildlife Laboratories, Inc. Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
WO2010065547A1 (en) * 2008-12-01 2010-06-10 Map Pharmaceuticals, Inc. Inhalation delivery methods and devices
US8555875B2 (en) * 2008-12-23 2013-10-15 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
US20130096170A1 (en) 2011-10-14 2013-04-18 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
WO2013069025A1 (en) 2011-11-11 2013-05-16 Neon Laboratories Ltd. "process for the preparation of dexmedetomidine"
US8242158B1 (en) 2012-01-04 2012-08-14 Hospira, Inc. Dexmedetomidine premix formulation
CA2924233C (en) 2013-10-07 2018-10-23 Teikoku Pharma Usa, Inc. Methods and compositions for treating attention deficit hyperactivity disorder, anxiety and insomnia using dexmedetomidine transdermal compositions
KR20180095732A (ko) 2013-10-07 2018-08-27 테이코쿠 팔마 유에스에이, 인코포레이티드 비진정량의 덱스메데토미딘의 경피 전달을 위한 방법 및 조성물
RU2646512C2 (ru) 2013-10-07 2018-03-05 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Устройства для трансдермальной доставки дексмедетомидина и способы их применения
US9717796B1 (en) 2016-04-20 2017-08-01 Slypharma, Llc Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container
US11839604B2 (en) 2016-12-31 2023-12-12 Bioxcel Therapeutics, Inc. Use of sublingual dexmedetomidine for the treatment of agitation
MX2020014000A (es) 2018-06-27 2021-06-15 Bioxcel Therapeutics Inc Formulaciones en lámina que contienen dexmedetomidina y métodos para producirlas.
US11160791B2 (en) 2018-11-01 2021-11-02 Medefil, Inc. Dexmedetomidine injection premix formulation in ready to use (RTU) bags
JP7739256B2 (ja) 2019-07-19 2025-09-16 バイオエクセル セラピューティクス，インコーポレイテッド 鎮静作用のないデクスメデトミジン治療レジメン
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8223082A (en) * 1981-04-22 1982-10-28 Farmos-Yhtyma Oy 2-phenyl-imidazole an imidazoline derivatives
AU552322B2 (en) * 1981-02-05 1986-05-29 Farmos-Yhtyma Oy Substituted imidazoles
AU566014B2 (en) * 1982-08-14 1987-10-08 Wellcome Foundation Limited, The Imidazole derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU552322B2 (en) * 1981-02-05 1986-05-29 Farmos-Yhtyma Oy Substituted imidazoles
AU8223082A (en) * 1981-04-22 1982-10-28 Farmos-Yhtyma Oy 2-phenyl-imidazole an imidazoline derivatives
AU566014B2 (en) * 1982-08-14 1987-10-08 Wellcome Foundation Limited, The Imidazole derivatives

Also Published As

Publication number Publication date
DK163960C (da) 1992-09-21
EP0187471B1 (en) 1991-07-31
DK508985D0 (da) 1985-11-05
DK508985A (da) 1986-06-05
EP0187471A2 (en) 1986-07-16
IE58269B1 (en) 1993-08-25
DK163960B (da) 1992-04-27
ATE65694T1 (de) 1991-08-15
DE3583670D1 (de) 1991-09-05
JPS61134314A (ja) 1986-06-21
AU4997185A (en) 1986-06-12
US4670455A (en) 1987-06-02
NZ213604A (en) 1988-09-29
ZA858416B (en) 1986-07-30
EP0187471A3 (en) 1988-09-14
FI844786A0 (fi) 1984-12-04
JPH0465050B2 (OSRAM) 1992-10-16
IE853024L (en) 1986-06-04

Similar Documents

Publication Publication Date Title
AU572364B2 (en) 4((alpha-methyl)-2,3-dimethylbenzyl)imidazole as a sedative-analgesic agent in the veterinary field
AU591740B2 (en) 2-((3,5-dihalo-4-aminobenzyl)) imidazolines
AU540763B2 (en) Pour on formulation, active against ticks
YU47204B (sh) Derivati didehidro-vitamina d3
AU565511B2 (en) 2-(imidazol-1-yl and 1, 2, 4-triazol-1-yl)-quinazolin derivatives
BG104056A (en) Triazole compounds and their use as dopamine-d3-ligands
AU1454188A (en) 3-substituted 1-(2-chlorothiazol-5-yl-methyl)-2-nitroimino- 1,3-diazacycloalkanes
AU4842479A (en) 1-(2-aryl-4,5-disubstituted-1,3-dioxolan-2-yl-methyl)-1h- imidazoles and 1h-1,2,4-triazoles
AU540613B2 (en) Anti inflamatory 4,5-diaryl-2(substituted - thio)pyrroles
AU8664082A (en) N-substituted 1,2,4 triosoles and imidazoles
AU2549484A (en) 1-(1,3-dioxolan-2-ylmethyl)azole derivatives
AU587995B2 (en) 1-substituted tetralin derivatives, their preparation and their use
AU585214B2 (en) Imidazole and 1,2,4-triazole derivatives
AU8539082A (en) Azabicyclo(3,2,1)octyl and (3,3,1) nonyl benzamides
AU646439B2 (en) Novel retinoids
AU6878787A (en) Substituted 5-(1,4-piperazinyl)-2,4-diaminopyridine
AU8174482A (en) 1-(1,2,4-triazol-1-yl)-2-cyano-ethanes
AU4973785A (en) N,n1 - disubstituted imidazoles useful as hypoglycemic agents
AU576393B2 (en) 1,2,4 - triazolo - carbamate compounds
AU585207B2 (en) Hydantoin derivatives, process for producing the same and medicine containing the same.
AU574606B1 (en) 1,5-diphenyl-1h-1,2,4-triazole-3-carboxamide derivatives
AU549146B2 (en) 1-(1,3-benzodioxol-5-yl)-2-pyrrolidinone
AU549459B2 (en) 1-(trihalomethyl-sulfenyl)-4-aryl-1,2,4-triazolidin-5- ones and fungici-des containing same
CA2250844A1 (en) Anti-hiv composition comprising imidazole derivatives
AU8028582A (en) Hexahydro-1,2,4-triazine-3,5-dione derivatives